December 03, 2024
4 min watch
Save
VIDEO: When, how to use remote monitoring to triage patients with rheumatoid arthritis
WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, spotlights a study evaluating the impact of remote monitoring of rheumatoid arthritis.
The data were presented at ACR Convergence 2024.
“I think it opens a whole new avenue about how to monitor and manage our patients, particularly as the work of rheumatology becomes limited,” Sparks, an associate professor of medicine at Harvard Medical School and an associate program director of the Rheumatology Fellowship, director of Immuno-Oncology and Autoimmunity and director of the Joint Biology Consortium Human Biosamples Core at Brigham and Women’s Hospital, told Healio.
Reference:
- Curtis J, et al. Abstract #0456. Presented at: ACR Convergence 2024; Nov. 14-19, 2024; Washington, D.C.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Sparks reports receiving research support from Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, and Sonoma Biotherapeutics; and serving as a consultant for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Fresenius Kabi, Gilead Sciences, Inova Diagnostics, Johnson & Johnson, Merck, MustangBio, Novartis, Optum, Pfizer, ReCor, Sana, Sobi, and UCB.
Read more about